History of falls in Parkinson disease is associated with reduced cholinergic activity
- 17 November 2009
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 73 (20), 1670-1676
- https://doi.org/10.1212/wnl.0b013e3181c1ded6
Abstract
Objective: To investigate the relationships between history of falls and cholinergic vs dopaminergic denervation in patients with Parkinson disease (PD). Background: There is a need to explore nondopaminergic mechanisms of gait control as the majority of motor impairments associated with falls in PD are resistant to dopaminergic treatment. Alterations in cholinergic neurotransmission in PD may be implicated because of evidence that gait control depends on cholinergic system–mediated higher-level cortical and subcortical processing, including pedunculopontine nucleus (PPN) function. Methods: In this cross-sectional study, 44 patients with PD (Hoehn & Yahr stages I–III) without dementia and 15 control subjects underwent a clinical assessment and [11C]methyl-4-piperidinyl propionate (PMP) acetylcholinesterase (AChE) and [11C]dihydrotetrabenazine (DTBZ) vesicular monoamine transporter type 2 (VMAT2) brain PET imaging. Results: Seventeen patients (38.6%) reported a history of falls and 27 patients had no falls. Analysis of covariance of the cortical AChE hydrolysis rates demonstrated reduced cortical AChE in the PD fallers group (−12.3%) followed by the PD nonfallers (−6.6%) compared to control subjects (F = 7.22, p = 0.0004). Thalamic AChE activity was lower only in the PD fallers group (−11.8%; F = 4.36, p = 0.008). There was no significant difference in nigrostriatal dopaminergic activity between PD fallers and nonfallers. Conclusions: Unlike nigrostriatal dopaminergic denervation, cholinergic hypofunction is associated with fall status in Parkinson disease (PD). Thalamic AChE activity in part represents cholinergic output of the pedunculopontine nucleus (PPN), a key node for gait control. Our results are consistent with other data indicating that PPN degeneration is a major factor leading to impaired postural control and gait dysfunction in PD.Keywords
This publication has 31 references indexed in Scilit:
- Poor attentional function predicts cognitive decline in patients with non-demented Parkinson's disease independent of motor phenotypeJournal of Neurology, Neurosurgery & Psychiatry, 2008
- The role of executive function and attention in gaitMovement Disorders, 2007
- Consensus Nomenclature for in vivo Imaging of Reversibly Binding RadioligandsJournal of Cerebral Blood Flow & Metabolism, 2007
- Postural Control, Gait, and Dopamine Functions in Parkinsonian Movement DisordersClinics in Geriatric Medicine, 2006
- Changes in motor subtype and risk for incident dementia in Parkinson's diseaseMovement Disorders, 2006
- Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2005
- Kinetic Analysis of [11C]MP4A Using a High-Radioactivity Brain Region That Represents an Integrated Input Function for Measurement of Cerebral Acetylcholinesterase Activity without Arterial Blood SamplingJournal of Cerebral Blood Flow & Metabolism, 2001
- A simple synthesis of [11C]Dihydrotetrabenazine (DTBZ)Nuclear Medicine and Biology, 1997
- Pharmacological evaluation of the cholinergic system in progressive supranuclear palsyAnnals of Neurology, 1994
- ParkinsonismNeurology, 1967